4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000108
Director sold 1,666 shares at $29.60 ($49,314)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-07-17 | Sale 10b5-1 | −1,666 | $29.60 | $49,314 | 133,037 | D |
| Open-market sales · 1,666 sh · avg $29.60 · $49,314 | |||||||
Loading xslF345X05/wk-form4_1689800946.xml…